Effect of histamine H4 and H1 receptor on allergic diseases
组胺H4和H1受体对过敏性疾病的影响
基本信息
- 批准号:22591099
- 负责人:
- 金额:$ 2.91万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2010
- 资助国家:日本
- 起止时间:2010 至 2012
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Histamine facilitates development of eczematous lesions in chronic allergic contact dermatitis. In addition to the well-known corticosteroid treatment, histamine H1 receptor (H1R) antagonists also have been used. This study observed effects of histamine H4 receptor (H4R) antagonist usage with H1R antagonist in a murine chronic allergic contact dermatitis model, developed by repeated percutaneous challenge to the dorsal skin with 2,4,6-trinitro-1-chlorobenzene (TNCB). The H1R antagonist olopatadine hydrochloride and/or the H4R antagonist JNJ7777120 were then administered. Combination therapy was more effective than H1R antagonist monotherapy. Serum IgE and levels of interleukin (IL)-4, IL-5 and IL-6 (Th2 cytokines) in eczematous lesions decreased with combined therapy. Combined therapy with H1R and H4R antagonists counteracts the disadvantages of each as monotherapeutic agents and potentially represents a new strategy for the treatment of chronic allergic contact dermatitis.
组胺促进慢性变应性接触性皮炎湿疹性病变的发展。除了众所周知的皮质类固醇治疗外,还使用了组胺H1受体(H1 R)拮抗剂。本研究观察了组胺H4受体(H4 R)拮抗剂与H1 R拮抗剂联合使用对小鼠慢性变应性接触性皮炎模型的影响,该模型通过反复经皮激发背部皮肤2,4,6-三硝基-1-氯苯(TNCB)而建立。然后给予H1 R拮抗剂盐酸奥洛他定和/或H4 R拮抗剂JNJ 7777120。联合治疗比H1 R拮抗剂单药治疗更有效。湿疹皮损中IL-4、IL-5和IL-6(Th 2细胞因子)水平和血清IgE水平在联合治疗后均下降。H1 R和H4 R拮抗剂的联合治疗抵消了各自作为单药的缺点,并可能代表治疗慢性变应性接触性皮炎的新策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Advantages of histamine H4 receptor antagonist usage with H1 receptor antagonist for the treatment of murine allergic contact dermatitis
- DOI:10.1111/j.1600-0625.2012.01559.x
- 发表时间:2012-09-01
- 期刊:
- 影响因子:3.6
- 作者:Matsushita, Ayuko;Seike, Masahiro;Ohtsu, Hiroshi
- 通讯作者:Ohtsu, Hiroshi
European Cooeration in Science and Technology
欧洲科技合作
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:W Baumer;T Werfel;R Seifert;M Kietzmann;D Neumann;R Khanferyan;H Ohtsu;M Seike;E Masini;SE Dahlen;A Sydbom;R Gutmer
- 通讯作者:R Gutmer
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SEIKE Masahiro其他文献
SEIKE Masahiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SEIKE Masahiro', 18)}}的其他基金
Prediction of drug sensitivity and development of a therapeutic strategy by microRNAs in lung cancer
肺癌中 microRNA 的药物敏感性预测和治疗策略的制定
- 批准号:
21591008 - 财政年份:2009
- 资助金额:
$ 2.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Effect of Histamine H4 receptor on allergic diseases
组胺H4受体对过敏性疾病的影响
- 批准号:
19591194 - 财政年份:2007
- 资助金额:
$ 2.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)